{"product_id":"textbook-of-hemophilia-isbn-9781118398241","title":"Textbook of Hemophilia","description":"\u003cp\u003eTextbook of Hemophilia, 3rd edition\u003c\/p\u003e \u003cp\u003eEdited by\u003cbr\u003e\u003cb\u003eChristine A. Lee, MA, MD, DSc, FRCP, FRCPath, FRCOG\u003cbr\u003e\u003c\/b\u003eEmeritus Professor of Haemophilia, University of London, London, UK\u003c\/p\u003e \u003cp\u003e\u003cb\u003eErik E. Berntorp, MD, PhD\u003cbr\u003e\u003c\/b\u003eProfessor of Coagulation Medicine, Lund University\u003cbr\u003eMalmö Centre for Thrombosis and Haemostasis, Skåne University Hospital, Malmö, Sweden\u003c\/p\u003e \u003cp\u003e\u003cb\u003eW. Keith Hoots, MD\u003cbr\u003e\u003c\/b\u003eDirector, Division of Blood Diseases and Resources, National Heart, Lung and Blood Institute\u003cbr\u003eNational Institutes of Health, Bethesda, MD;\u003cbr\u003eProfessor of Pediatrics and Internal Medicine, University of Texas Medical School at Houston, Houston, TX, USA\u003c\/p\u003e \u003cp\u003eWithout doubt, \u003cb\u003eTextbook of Hemophilia, 3rd edition\u003c\/b\u003e is \u003ci\u003ethe\u003c\/i\u003e definitive reference source on all aspects of haemophilia including diagnosis, management and treatment. Edited by three, world-renowned experts on haemophilia, this completely revised resource features chapters written by over 60 international contributors with international expertise in caring for haemophilia patients.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eTextbook of Hemophilia, 3rd edition\u003c\/b\u003e\u003c\/p\u003e \u003cul\u003e \u003cli\u003eFeatures eight new chapters, covering individualised dosing, vCJD and haemophilia, new drugs in the pipeline, and surgery in inhibitor patients\u003c\/li\u003e \u003cli\u003ePresents new developments, such as gene therapy\u003c\/li\u003e \u003cli\u003eHighlights controversial issues and provides advice for everyday clinical questions\u003c\/li\u003e \u003cli\u003eRepresents essential reading for all healthcare professionals involved in the care of those with haemophilia\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003e\u003cb\u003eTitles of related interest\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eHemophilia and Hemostasis: A Case-Based Approach to Management, 2nd Edition\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ehttp:\/\/eu.wiley.com\/WileyCDA\/Section\/id-302479.html, ISBN: 9780470659762\u003c\/p\u003e \u003cp\u003e\u003ci\u003eCurrent and Future Issues in Hemophilia Care\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ehttp:\/\/eu.wiley.com\/WileyCDA\/Section\/id-302479.html?query=E.+Carlos+Rodriguez-Merchan, ISBN: 9780470670576\u003c\/p\u003e \u003cp\u003ehttp:\/\/www.wiley.com\/go\/hematology\u003c\/p\u003e \u003cp\u003eContributors ix\u003c\/p\u003e \u003cp\u003eHistorical introduction xv\u003cbr\u003e \u003ci\u003eChristine A. Lee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart I: Introduction\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Overview of hemostasis 3\u003cbr\u003e \u003ci\u003eKathleen Brummel Ziedins and Kenneth G. Mann\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Cellular processing of factor VIII and factor IX 9\u003cbr\u003e \u003ci\u003eMichael U. Callaghan and Randal J. Kaufman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II: Hemophilia A\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e3 Molecular basis of hemophilia A 23\u003cbr\u003e \u003ci\u003eGeoffrey Kemball-Cook and Keith Gomez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Prophylaxis 33\u003cbr\u003e \u003ci\u003eKathelijn Fischer and H. Marijke van den Berg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III: Inhibitors to Factor VIII\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e5 Inhibitors to factor VIII: immunology 43\u003cbr\u003e \u003ci\u003eJean-Marie R. Saint-Remy and Marc G. Jacquemin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Genetic and Environmental Risk Factors for Factor VIII inhibitor development 48\u003cbr\u003e \u003ci\u003eJan Astermark\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Epidemiology of inhibitors in hemophilia 53\u003cbr\u003e \u003ci\u003eAlfonso Iorio\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Inhibitors to factor VIII: mild and moderate hemophilia 59\u003cbr\u003e \u003ci\u003eKathelijne Peerlinck and Marc Jacquemin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Inhibitors to factor VIII\/IX: immune tolerance 64\u003cbr\u003e \u003ci\u003eDonna M. DiMichele\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Prophylaxis in inhibitor patients 72\u003cbr\u003e \u003ci\u003eAlessandro Gringeri\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Inhibitors to factor VIII: treatment of acute bleeds 78\u003cbr\u003e \u003ci\u003eClaude Negrier\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart IV: Acquired Hemophilia\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e12 Acquired inhibitors to factor VIII 87\u003cbr\u003e \u003ci\u003eCraig M. Kessler\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart V: Hemophilia B\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e13 Hemophilia B: molecular basis 97\u003cbr\u003e \u003ci\u003eKeith Gomez and Pratima Chowdary\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Factor IX inhibitors in hemophilia B 103\u003cbr\u003e \u003ci\u003eMeera B. Chitlur and Jeanne M. Lusher\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Treatment of inhibitors in hemophilia B 107\u003cbr\u003e \u003ci\u003eAnand Tandra and Amy D. Shapiro\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart VI: Pharmacokinetics of Factors VIII and IX\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e16 Pharmacokinetics 117\u003cbr\u003e \u003ci\u003eSven Björkman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Individualized dosing 123\u003cbr\u003e \u003ci\u003ePeter W. Collins\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart VII: Hemophilia: Birth to Old Age\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e18 Neonate with hemophilia 131\u003cbr\u003e \u003ci\u003eAngela E. Thomas and Elizabeth A. Chalmers\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Work-up of a bleeding child 138\u003cbr\u003e \u003ci\u003eManuel D. Carcao and Victor S. Blanchette\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Care of the child with hemophilia 145\u003cbr\u003e \u003ci\u003eRolf C.R. Ljung\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Hemophilia in adolescence 150\u003cbr\u003e \u003ci\u003ePia Petrini\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Old age medicine and hemophilia 154\u003cbr\u003e \u003ci\u003eEvelien P. Mauser-Bunschoten and Roger E.G. Schutgens\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart VIII: Products Used to Treat Hemophilia\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e23 Products used to treat hemophilia: recombinant products 165\u003cbr\u003e \u003ci\u003eMidori Shima and Akira Yoshioka\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Products used to treat hemophilia: plasma-derived coagulation factor concentrates 174\u003cbr\u003e \u003ci\u003ePaul L.F. Giangrande\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25 Products used to treat hemophilia: dosing 180\u003cbr\u003e \u003ci\u003eMiguel A. Escobar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26 Products used to treat hemophilia: regulation 185\u003cbr\u003e \u003ci\u003eAlbert Farrugia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27 New drugs in the pipeline: from concept to clinic 192\u003cbr\u003e \u003ci\u003eLeonard A. Valentino\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart IX: Surgical management\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e28 General surgical management of patients with hemophilia 199\u003cbr\u003e \u003ci\u003eCindy Leissinger and Rebecca Kruse-Jarres\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e29 Continuous infusion of coagulation products in hemophilia 204\u003cbr\u003e \u003ci\u003eAngelika Batorova and Uri Martinowitz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30 Surgery in inhibitor patients 213\u003cbr\u003e \u003ci\u003ePål Andrè Holme\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart X: Musculoskeletal\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e31 Joint replacement in patients with hemophilia 221\u003cbr\u003e \u003ci\u003eNicholas Goddard\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e32 Medical synovectomy (synoviorthesis) in hemophilia: radiosynovectomy and chemical synovectomy 228\u003cbr\u003e \u003ci\u003eE. Carlos Rodriguez-Merchan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e33 Pseudotumors in patients with hemophilia 233\u003cbr\u003e \u003ci\u003eMichael Heim and Uri Martinowitz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34 Imaging modalities for assessment of hemophilic arthropathy 237\u003cbr\u003e \u003ci\u003eAndrea S. Doria and Björn Lundin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e35 Physiotherapy in the management of hemophilia 247\u003cbr\u003e \u003ci\u003eSébastien Lobet and David Stephensen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e36 Outcome assessment in hemophilia 253\u003cbr\u003e \u003ci\u003ePradeep M. Poonnoose and Alok Srivastava\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart XI: Transfusion-transmitted Disease\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e37 Viral hepatitis and hemophilia 265\u003cbr\u003e \u003ci\u003eMichael Makris and Geoffrey Dusheiko\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e38 Transfusion-transmitted disease: emerging infections 272\u003cbr\u003e \u003ci\u003eThomas R. Kreil\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e39 vCJD and hemophilia 277\u003cbr\u003e \u003ci\u003eCarolyn M. Millar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart XII: Gene Therapy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e40 Hemophilia gene therapy: an overview 285\u003cbr\u003e \u003ci\u003eDavid Lillicrap\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e41 Gene therapy trials in hemophilia A and B 291\u003cbr\u003e \u003ci\u003eKatherine A. High\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e42 Gene therapy: molecular engineering of factor VIII and factor IX 298\u003cbr\u003e \u003ci\u003eSundar R. Selvaraj and Steven W. Pipe\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart XIII: Laboratory\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e43 Laboratory and quality control of assays 311\u003cbr\u003e \u003ci\u003eSteve Kitchen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e44 Standardization of assays in hemophilia 318\u003cbr\u003e \u003ci\u003eSanj Raut and Trevor W. Barrowcliffe\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e45 Global laboratory assays in hemophilia 328\u003cbr\u003e \u003ci\u003eBenny Sørensen and Guy Young\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart XIV: Women and Bleeding Disorders\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e46 Obstetrics and gynecology: hemophilia 337\u003cbr\u003e \u003ci\u003eRezan A. Kadir and Christine A. Lee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e47 Women and von Willebrand disease 345\u003cbr\u003e \u003ci\u003ePeter A. Kouides\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart XV: von Willebrand Disease\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e48 von Willebrand disease: molecular aspects 355\u003cbr\u003e \u003ci\u003eDaniel Hampshire and Anne Goodeve\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e49 von Willebrand disease: epidemiology 362\u003cbr\u003e \u003ci\u003eFrancesco Rodeghiero and Giancarlo Castaman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e50 von Willebrand disease: biological diagnosis 370\u003cbr\u003e \u003ci\u003eVeronica H. Flood and Robert R. Montgomery\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e51 Classification and clinical aspects of von Willebrand disease 377\u003cbr\u003e \u003ci\u003eAugusto B. Federici\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e52 Treatment of von Willebrand disease: desmopressin 386\u003cbr\u003e \u003ci\u003ePier M. Mannucci\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e53 Treatment of von Willebrand disease: therapeutic concentrates 390\u003cbr\u003e \u003ci\u003eErik E. Berntorp\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart XVI: Rare Bleeding Disorders\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e54 Factor II 399\u003cbr\u003e \u003ci\u003eJan Astermark\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e55 Factor V and combined factor V and VIII deficiencies 403\u003cbr\u003e \u003ci\u003eFlora Peyvandi and Marzia Menegatti\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e56 Congenital factor VII deficiency 413\u003cbr\u003e \u003ci\u003eAngelika Batorova\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e57 Factor X and factor X deficiency 421\u003cbr\u003e \u003ci\u003eDavid J. Perry\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e58 Factor XI deficiency 428\u003cbr\u003e \u003ci\u003ePaula H.B. Bolton-Maggs and Uri Seligsohn\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e59 Factor XIII deficiency 436\u003cbr\u003e \u003ci\u003eDiane Nugent and Loan Hsieh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e60 Fibrinogen deficiency 445\u003cbr\u003e \u003ci\u003eMichael Laffan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e61 Miscellaneous rare bleeding disorders 452\u003cbr\u003e \u003ci\u003eFrederico Xavier and Amy D. Shapiro\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart XVII: Emergency Medicine\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e62 Emergency management of hemophilia 463\u003cbr\u003e \u003ci\u003eW. Keith Hoots\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart XVIII: Evaluation of Hemophilia\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e63 Clinical trials and other methodologies 473\u003cbr\u003e \u003ci\u003eSharyne M. Donfield and Alice E. Lail\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e64 Quality of life in hemophilia 478\u003cbr\u003e \u003ci\u003eSylvia von Mackensen and Alessandro Gringeri\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e65 The economics of hemophilia treatment 489\u003cbr\u003e \u003ci\u003eKatarina Steen Carlsson and Erik E. Berntorp\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart XIX: Comprehensive Care and Delivery of Care\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e66 Hemophilia databases 497\u003cbr\u003e \u003ci\u003eCharles R.M. Hay\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e67 Comprehensive care and delivery of care: the developed world 502\u003cbr\u003e \u003ci\u003eChristopher A. Ludlam and Cedric R.J.R. Hermans\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e68 Comprehensive care and delivery of care in hemophilia: the developing world 508\u003cbr\u003e \u003ci\u003eAlok Srivastava and Auro Viswabandya\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e69 Comprehensive care and delivery of care: the global perspective 515\u003cbr\u003e \u003ci\u003eMark W. Skinner and Alison M. Street\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 523\u003c\/p\u003e \u003cp\u003eColor plate section can be found facing page 202\u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eChristine A. Lee\u003c\/strong\u003e, MA, MD, DSc, FRCP, FRCPath, Emeritus Professor of Haemophilia, University of London; Honorary Consultant Haematologist, Oxford Haemophilia \u0026amp; Thrombosis Centre, Oxford, UK. \u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eErik E. Berntorp\u003c\/strong\u003e, MD, PhD, Professor of Hemophilia, Lund University; Director, Department of Coagulation Disorders, Malmo University Hospital, Malmo, Sweden. \u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eW. Keith Hoots\u003c\/strong\u003e, MD, Professor of Pediatrics, University of Texas M.D. Anderson Cancer Center; Professor of Pediatrics and Internal Medicine, University of Texas Medical School at Houston; Medical Director, Gulf States Hemophilia and Thrombophilia Center, Houston, Texas, USA.  \u003c\/p\u003e\u003cp\u003eTextbook of Hemophilia, 3rd edition\u003c\/p\u003e \u003cp\u003eEdited by\u003cbr\u003e\u003cb\u003eChristine A. Lee, MA, MD, DSc, FRCP, FRCPath, FRCOG\u003cbr\u003e\u003c\/b\u003eEmeritus Professor of Haemophilia, University of London, London, UK\u003c\/p\u003e \u003cp\u003e\u003cb\u003eErik E. Berntorp, MD, PhD\u003cbr\u003e\u003c\/b\u003eProfessor of Coagulation Medicine, Lund University\u003cbr\u003eMalmö Centre for Thrombosis and Haemostasis, Skåne University Hospital, Malmö, Sweden\u003c\/p\u003e \u003cp\u003e\u003cb\u003eW. Keith Hoots, MD\u003cbr\u003e\u003c\/b\u003eDirector, Division of Blood Diseases and Resources, National Heart, Lung and Blood Institute\u003cbr\u003eNational Institutes of Health, Bethesda, MD;\u003cbr\u003eProfessor of Pediatrics and Internal Medicine, University of Texas Medical School at Houston, Houston, TX, USA\u003c\/p\u003e \u003cp\u003eWithout doubt, \u003cb\u003eTextbook of Hemophilia, 3rd edition\u003c\/b\u003e is \u003ci\u003ethe\u003c\/i\u003e definitive reference source on all aspects of haemophilia including diagnosis, management and treatment. Edited by three, world-renowned experts on haemophilia, this completely revised resource features chapters written by over 60 international contributors with international expertise in caring for haemophilia patients.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eTextbook of Hemophilia, 3rd edition\u003c\/b\u003e\u003c\/p\u003e \u003cul\u003e \u003cli\u003eFeatures eight new chapters, covering individualised dosing, vCJD and haemophilia, new drugs in the pipeline, and surgery in inhibitor patients\u003c\/li\u003e \u003cli\u003ePresents new developments, such as gene therapy\u003c\/li\u003e \u003cli\u003eHighlights controversial issues and provides advice for everyday clinical questions\u003c\/li\u003e \u003cli\u003eRepresents essential reading for all healthcare professionals involved in the care of those with haemophilia\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003e\u003cb\u003eTitles of related interest\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eHemophilia and Hemostasis: A Case-Based Approach to Management, 2nd Edition\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ehttp:\/\/eu.wiley.com\/WileyCDA\/Section\/id-302479.html, ISBN: 9780470659762\u003c\/p\u003e \u003cp\u003e\u003ci\u003eCurrent and Future Issues in Hemophilia Care\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ehttp:\/\/eu.wiley.com\/WileyCDA\/Section\/id-302479.html?query=E.+Carlos+Rodriguez-Merchan, ISBN: 9780470670576\u003c\/p\u003e \u003cp\u003ehttp:\/\/www.wiley.com\/go\/hematology\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47990146695397,"sku":"NP9781118398241","price":189.5,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781118398241.jpg?v=1761786681","url":"https:\/\/k12savings.com\/es\/products\/textbook-of-hemophilia-isbn-9781118398241","provider":"K12savings","version":"1.0","type":"link"}